Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
Purpose: To study the prognostic significance of the presence of breast cancer-specific mRNA transcripts in peripheral blood (PB), defined by serial analysis of gene expression, in high-risk breast cancer (HRBC) patients undergoing high-dose chemotherapy after receiving adjuvant chemotherapy.Methods...
| Published in: | Journal of Clinical Oncology Vol. 24; no. 22; pp. 3611 - 3619 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | research Journal Article |
| Published: |
American Society of Clinical Oncology
8/1/2006
|
| Online Access: | View this record in EBSCOhost |